The buying signal from two executives is mildly positive but too small in magnitude to suggest strong conviction; monitor for follow-up purchases or larger capital commitments.
Price Chart
Executive Summary
A cluster of insider transactions at Generate Biomedicines (GENB) over the past week includes two open-market purchases totaling $32,000 by executives Mendillo Jane L and Silvers Jason, alongside multiple non-cash derivative conversions by insiders including CEO Michael Nally and others. The purchases are small in absolute value and represent minimal economic activity relative to the company's market cap.
Key Financial Metrics
Key Facts
- Two open-market purchases occurred: Mendillo Jane L bought 1,500 shares ($24,000) and Silvers Jason (President & CFO) bought 500 shares ($8,000).
- Multiple non-cash derivative conversions totaling over 26 million shares were executed at $0 value, including by CEO Michael Nally and Stephane Bancel.
- Total open-market buying: $32,000 over 7 days, consistent with recent 30-day activity.
- No open-market selling occurred in the cluster.
Financial Impact
$32,000 in open-market purchases, representing a negligible fraction of market cap (<0.01%)
Risk Factors
- Non-cash transactions (conversions) dominate the cluster and do not reflect actual buying or selling activity.
- Small purchase size limits predictive value for stock performance.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (6 trades, 7d window) | cluster-GENB-1772492108578 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 7, 2026 21w ago | 8-K | $13.59 $14.34 | ▼ −5.52% | ▼ −1.69% | $13.54 (+0.37%) |
Mar 2, 2026 30w ago | Insider Cluster | $12.17 $13.34 | ▲ +9.61% | ▲ +0.29% | $13.54 (+11.26%) |
Mar 2, 2026 30w ago | Insider Cluster | $12.17 $13.34 | ▲ +9.61% | ▲ +0.29% | $13.54 (+11.26%) |
Feb 27, 2026 30w ago | 424B4 | $12.17 $13.34 | ▼ −9.61% | ▼ −0.29% | $13.54 (−11.26%) |
Feb 27, 2026 31w ago | EFFECT | $12.65 $13.34 | ▲ +5.45% | ▼ −3.93% | $13.54 (+7.04%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access